Literature DB >> 15895085

Ovarian cycle-linked changes in GABA(A) receptors mediating tonic inhibition alter seizure susceptibility and anxiety.

Jamie L Maguire1, Brandon M Stell, Mahsan Rafizadeh, Istvan Mody.   

Abstract

Disturbances of neuronal excitability changes during the ovarian cycle may elevate seizure frequency in women with catamenial epilepsy and enhance anxiety in premenstrual dysphoric disorder (PMDD). The mechanisms underlying these changes are unknown, but they could result from the effects of fluctuations in progesterone-derived neurosteroids on the brain. Neurosteroids and some anxiolytics share an important site of action: tonic inhibition mediated by delta subunit-containing GABA(A) receptors (deltaGABA(A)Rs). Here we demonstrate periodic alterations in specific GABA(A)R subunits during the estrous cycle in mice, causing cyclic changes of tonic inhibition in hippocampal neurons. In late diestrus (high-progesterone phase), enhanced expression of deltaGABA(A)Rs increases tonic inhibition, and a reduced neuronal excitability is reflected by diminished seizure susceptibility and anxiety. Eliminating cycling of deltaGABA(A)Rs by antisense RNA treatment or gene knockout prevents the lowering of excitability during diestrus. Our findings are consistent with possible deficiencies in regulatory mechanisms controlling normal cycling of deltaGABA(A)Rs in individuals with catamenial epilepsy or PMDD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15895085     DOI: 10.1038/nn1469

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  278 in total

1.  The influence of sex and estrous cycle on QTL for emotionality and ethanol consumption.

Authors:  Geison S Izídio; Letícia C Oliveira; Lígia F G Oliveira; Elayne Pereira; Thaize D Wehrmeister; André Ramos
Journal:  Mamm Genome       Date:  2011-04-24       Impact factor: 2.957

Review 2.  GABA receptor-mediated effects in the peripheral nervous system: A cross-interaction with neuroactive steroids.

Authors:  Valerio Magnaghi; Marinella Ballabio; Antonio Consoli; Jeremy J Lambert; Ilaria Roglio; Roberto C Melcangi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

3.  Type 1 5α-reductase may be required for estrous cycle changes in affective behaviors of female mice.

Authors:  Carolyn J Koonce; Alicia A Walf; Cheryl A Frye
Journal:  Behav Brain Res       Date:  2011-09-21       Impact factor: 3.332

4.  Postnatal and adult exposure to estradiol differentially influences adult neurogenesis in the main and accessory olfactory bulb of female mice.

Authors:  Alexandra Veyrac; Julie Bakker
Journal:  FASEB J       Date:  2010-12-09       Impact factor: 5.191

5.  Cellular correlates of anxiety in CA1 hippocampal pyramidal cells of 5-HT1A receptor knockout mice.

Authors:  Emily Freeman-Daniels; Sheryl G Beck; Lynn G Kirby
Journal:  Psychopharmacology (Berl)       Date:  2010-10-28       Impact factor: 4.530

6.  Simultaneous quantification of GABAergic 3alpha,5alpha/3alpha,5beta neuroactive steroids in human and rat serum.

Authors:  Patrizia Porcu; Todd K O'Buckley; Sarah E Alward; Christine E Marx; Lawrence J Shampine; Susan S Girdler; A Leslie Morrow
Journal:  Steroids       Date:  2009-01-13       Impact factor: 2.668

7.  Neuroprotection against excitotoxic brain injury in mice after ovarian steroid depletion.

Authors:  P Elyse Schauwecker; Ruth I Wood; Ariana Lorenzana
Journal:  Brain Res       Date:  2009-02-21       Impact factor: 3.252

Review 8.  Extrasynaptic GABAA receptors in the crosshairs of hormones and ethanol.

Authors:  Istvan Mody
Journal:  Neurochem Int       Date:  2007-07-17       Impact factor: 3.921

Review 9.  Divergent neuroactive steroid responses to stress and ethanol in rat and mouse strains: relevance for human studies.

Authors:  Patrizia Porcu; A Leslie Morrow
Journal:  Psychopharmacology (Berl)       Date:  2014-04-26       Impact factor: 4.530

10.  Differences in the reinstatement of ethanol seeking with ganaxolone and gaboxadol.

Authors:  M J Ramaker; M M Ford; T J Phillips; D A Finn
Journal:  Neuroscience       Date:  2014-05-09       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.